← Back to headlines
FDA Requests More Data from Eli Lilly for Obesity Drug
Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has requested additional clinical data regarding its experimental obesity pill, potentially delaying its approval.
19 Apr, 05:03 — 19 Apr, 05:03
Sources
Showing 1 of 1 sources
